Nautilus Biotechnology, Inc.
NAUT· Nasdaq
NAUTNautilus Biotechnology, Inc.
Filed May 3, 2022 · 10-Q · 33 days after period end · 0001808805-22-000046
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net Income | -$15.76M | -$8.41M |
| EPS Diluted | -$0.13 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nautilus Biotechnology, Inc. · CIK 1808805 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 3, 2022 · 33 d after period end
